Former govt. investing in low-yields led to debt rise - Champika

Former govt. investing in low-yields led to debt rise - Champika

January 30, 2019   02:43 pm

The debt loans that the government has to pay back are three times the amount in comparison to the debt loans of the year 2010, says the Minister of Megapolis & Western Development Patali Champika Ranawaka.

The situation was caused by the former government’s investments on the low-yielding projects, the minister added.

A discussion on the developmental activities in Weligama area in Matara was headed by Minister Ranawaka.

The minister made these comments during the discussion that took place at the auditorium of Weligama Urban Council last evening (29).

Minister Ranawaka had also declared open and officially handed over the newly-built seafood stalls on the coastline of Weligama Sea to the fish traders yesterday.

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories

President commends Sri Lanka Army for its unwavering service to the nation (English)

President commends Sri Lanka Army for its unwavering service to the nation (English)

Several parties comment on controversies over the 'Ondansetron' vaccine (English)

Reservoirs continue to overflow, landslides reported amid Northeast Monsoon rains (English)

Justice Minister invites public to share views on proposed new Anti-Terrorism Bill (English)

LIVE🔴Ada Derana Prime Time News Bulletin 6.55 pm

Probe launched after reports of VMS data falling into drug traffickers' hands (English)

PM calls for united front to eradicate ragging, violence and narcotics from universities (English)

Indian pharma company requests independent testing of controversial drug withdrawn in Sri Lanka (English)